|
|
Article: Chemokine Therapeutics Focuses Effort On Cytokines, Chemokines.
- Article from:
- BIOWORLD Today
- Article date:
- November 4, 2009
CopyrightCOPYRIGHT 2009 A Thomson Healthcare Company. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Staff Writer
In the biotechnology world, chemokines are "getting very hot," said Hassan Salari, president and CEO of Chemokine Therapeutics Corp. And while some biotechnology firms search the earth and oceans for compounds, Chemokine Therapeutics designs its own molecules.
The Vancouver, British Columbia-based company is focused not only on chemokines, but also cytokines. Chemokine Therapeutics was founded in 2000 by Salari and to date has raised about $8 million. Salari has served as a professor at the University of British Columbia and was a founder of Inflazyme Pharmaceuticals Ltd., also of Vancouver. Today, Salari's company has 14 employees, and has ...